KIM LLC’s LumiraDx Limited Warrant LMDXW Stock Holding History

KIM LLC’s Portfolio LMDXW Stock Details LMDXW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-125,000	Closed	-$938	–	370
2023 Q4	$938	Hold	125,000	–	–	﹤0.01%	333
2023 Q3	$4.51K	Hold	125,000	–	–	﹤0.01%	341
2023 Q2	$3.74K	Hold	125,000	–	–	﹤0.01%	393
2023 Q1	$10.6K	Hold	125,000	–	–	﹤0.01%	389
2022 Q4	$7K	Hold	125,000	–	–	﹤0.01%	494
2022 Q3	$14K	Hold	125,000	–	–	﹤0.01%	596
2022 Q2	$113K	Buy	+125,000	New	+$108K	0.01%	469

Other funds holding LMDXW

CVS Health Woonsocket, Rhode Island $212M AUM 19.39% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

KIM LLC's LMDXW Position: Q1 2024 in Review

KIM LLC sold out of LumiraDx Limited Warrant (LMDXW) in Q1 2024, closing a stake of 125,000 shares — an estimated $938 sold.

KIM LLC first reported a position in LMDXW in Q2 2022 and held it in 7 quarters. The position peaked at $113K in Q2 2022. 4 funds tracked by Wall St. Rank hold LMDXW as of Q1 2024.

KIM LLC reported no remaining LumiraDx Limited Warrant position as of Q1 2024 after selling out during the quarter.
KIM LLC sold 125,000 LumiraDx Limited Warrant shares in Q1 2024, an estimated $938.
KIM LLC first reported a position in LumiraDx Limited Warrant in Q2 2022 and held it in 7 quarters.
KIM LLC's LumiraDx Limited Warrant position peaked at $113K in Q2 2022.
4 funds tracked by Wall St. Rank held LumiraDx Limited Warrant as of Q1 2024.

Based on KIM LLC's 13F filing for Q1 2024, filed 13 May 2024.